Current Value
$146.701 Year Return
Current Value
$146.701 Year Return
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TEF | -0.12% | $29.18B | +18.85% | 6.34% |
| UL | -0.19% | $147.86B | +5.09% | 3.22% |
| LRN | 0.20% | $5.85B | +86.17% | 0.00% |
| ZCMD | 0.41% | $28.28M | -14.50% | 0.00% |
| KR | -0.42% | $47.52B | +34.10% | 1.78% |
| DRD | -0.46% | $1.16B | +26.57% | 2.04% |
| KEP | -0.47% | $17.06B | +86.40% | 0.56% |
| NOC | 0.52% | $74.38B | +18.77% | 1.63% |
| SKWD | 0.52% | $2.17B | +35.56% | 0.00% |
| EXC | 0.54% | $43.36B | +20.92% | 3.63% |
| HLN | 0.59% | $43.71B | +11.20% | 1.82% |
| GFI | -0.67% | $21.72B | +43.10% | 2.32% |
| CARV | -0.69% | $9.34M | +22.67% | 0.00% |
| BTCT | 0.75% | $23.60M | +61.00% | 0.00% |
| LFVN | -0.75% | $159.62M | +98.44% | 1.28% |
| FMS | -0.77% | $15.77B | +36.33% | 3.02% |
| BTI | 0.82% | $112.58B | +60.14% | 5.89% |
| PM | -0.82% | $281.61B | +70.52% | 2.97% |
| GALT | 0.85% | $177.22M | +11.11% | 0.00% |
| AWR | -0.85% | $2.88B | -5.67% | 2.49% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| IQV | 75.38% | $27.28B | -32.32% | 0.00% |
| TMO | 57.16% | $157.79B | -24.74% | 0.39% |
| BRKR | 55.94% | $6.36B | -36.66% | 0.48% |
| A | 55.27% | $32.08B | -16.99% | 0.86% |
| MEDP | 54.61% | $8.99B | -31.62% | 0.00% |
| CRL | 54.52% | $7.58B | -32.07% | 0.00% |
| DHR | 54.34% | $138.02B | -23.51% | 0.61% |
| RVTY | 54.05% | $11.30B | -15.22% | 0.29% |
| TECH | 53.56% | $8.06B | -35.58% | 0.62% |
| TER | 51.59% | $14.92B | -42.93% | 0.53% |
| WEX | 51.46% | $5.11B | -21.41% | 0.00% |
| MTD | 51.03% | $24.29B | -15.50% | 0.00% |
| AZTA | 49.68% | $1.46B | -44.20% | 0.00% |
| BIO | 49.35% | $6.73B | -21.36% | 0.00% |
| HAS | 49.24% | $10.49B | +20.48% | 3.72% |
| LEA | 48.43% | $5.63B | -14.99% | 2.90% |
| TXT | 47.61% | $15.25B | -10.18% | 0.09% |
| CARR | 47.07% | $64.62B | +7.87% | 0.85% |
| VLTO | 46.37% | $25.02B | +1.76% | 0.42% |
| ILMN | 46.04% | $15.38B | -22.42% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TAIL | -37.96% | $94.79M | 0.59% |
| VIXY | -34.60% | $198.83M | 0.85% |
| VIXM | -31.97% | $23.12M | 0.85% |
| BTAL | -28.55% | $310.74M | 1.43% |
| IVOL | -27.18% | $342.76M | 1.02% |
| FXY | -18.69% | $793.88M | 0.4% |
| TPMN | -18.38% | $31.00M | 0.65% |
| FTSD | -17.80% | $233.17M | 0.25% |
| SPTS | -16.47% | $5.78B | 0.03% |
| XHLF | -15.45% | $1.75B | 0.03% |
| XONE | -15.38% | $629.19M | 0.03% |
| UTWO | -13.05% | $376.61M | 0.15% |
| IBTG | -12.95% | $1.93B | 0.07% |
| CLIP | -12.27% | $1.51B | 0.07% |
| IBTH | -12.14% | $1.62B | 0.07% |
| SHYM | -12.06% | $355.36M | 0.35% |
| VGSH | -11.30% | $22.74B | 0.03% |
| FXE | -10.86% | $593.51M | 0.4% |
| UDN | -10.62% | $146.96M | 0.78% |
| SCHO | -10.22% | $10.92B | 0.03% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BBH | 61.91% | $339.74M | 0.35% |
| IBB | 56.32% | $5.48B | 0.45% |
| VHT | 54.23% | $15.33B | 0.09% |
| FHLC | 54.15% | $2.43B | 0.084% |
| IYH | 53.41% | $2.73B | 0.39% |
| GNOM | 53.21% | $44.39M | 0.5% |
| PBE | 52.76% | $229.54M | 0.58% |
| FBT | 52.56% | $1.03B | 0.54% |
| RSPH | 51.96% | $718.84M | 0.4% |
| XLV | 51.65% | $33.63B | 0.09% |
| IXJ | 51.61% | $3.76B | 0.41% |
| MOAT | 51.08% | $12.85B | 0.47% |
| QQQJ | 51.06% | $625.62M | 0.15% |
| FXH | 50.89% | $880.12M | 0.62% |
| XPH | 50.14% | $168.46M | 0.35% |
| XBI | 49.73% | $5.07B | 0.35% |
| IHE | 49.46% | $557.84M | 0.39% |
| DSTL | 47.24% | $1.80B | 0.39% |
| SMOT | 47.19% | $397.55M | 0.49% |
| DUHP | 46.58% | $8.80B | 0.21% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| IBTP | -0.16% | $142.92M | 0.07% |
| STXT | 0.20% | $128.49M | 0.49% |
| GVI | -0.22% | $3.44B | 0.2% |
| CMBS | -0.30% | $455.62M | 0.25% |
| UNG | -0.31% | $422.40M | 1.06% |
| NEAR | 0.31% | $3.37B | 0.25% |
| WEAT | -0.40% | $122.74M | 0.28% |
| JPST | -0.54% | $32.06B | 0.18% |
| CGSD | 0.58% | $1.40B | 0.25% |
| IAGG | 0.63% | $10.52B | 0.07% |
| FLIA | -0.66% | $705.51M | 0.25% |
| JMST | 0.76% | $4.09B | 0.18% |
| JUCY | -0.77% | $256.64M | 0.6% |
| IBMN | 0.81% | $445.32M | 0.18% |
| SMB | 0.84% | $276.82M | 0.07% |
| LGOV | -0.99% | $645.78M | 0.67% |
| IBTF | 1.03% | $1.98B | 0.07% |
| FMHI | 1.04% | $748.03M | 0.7% |
| CGCB | -1.05% | $2.62B | 0.27% |
| UTEN | -1.21% | $210.49M | 0.15% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| AMSF | -19.09% | $848.31M | -0.99% | 3.41% |
| CME | -16.25% | $99.10B | +42.79% | 1.75% |
| LTM | -12.69% | $12.66B | -95.54% | 2.41% |
| ADT | -11.94% | $7.00B | +8.84% | 2.62% |
| MOH | -11.91% | $11.63B | -30.17% | 0.00% |
| STG | -10.43% | $60.94M | +42.06% | 0.00% |
| CBOE | -10.03% | $24.50B | +35.35% | 1.07% |
| MKTX | -9.56% | $8.05B | -3.20% | 1.40% |
| ACIC | -8.43% | $520.28M | -1.89% | 0.00% |
| GSHD | -6.83% | $2.41B | +64.18% | 0.00% |
| MO | -6.76% | $98.51B | +21.76% | 6.95% |
| MTLS | -6.15% | $339.05M | +7.29% | 0.00% |
| UUU | -5.76% | $7.17M | +113.79% | 0.00% |
| DFDV | -5.54% | $363.80M | +2,684.66% | 0.00% |
| AIFU | -5.22% | $20.27M | +118.75% | 0.00% |
| MVO | -4.87% | $66.47M | -38.71% | 25.62% |
| TMUS | -4.38% | $256.63B | +23.52% | 1.45% |
| VSA | -4.27% | $12.16M | +18.21% | 0.00% |
| MCK | -3.78% | $88.78B | +21.73% | 0.40% |
| VSTA | -3.71% | $336.05M | +39.20% | 0.00% |
Finnhub
ICON plc, a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations for phase 1 clinical trials in a...
Yahoo
Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here. The equity portfolio returned 4.67% in the second quarter compared to 10.94% for the S&P 500 Index. An underweight in technology stocks and an overweight in value and mid-cap stocks […]
SeekingAlpha
During the month of June the LRT Global Opportunities strategy returned -1.30% net of fees. Year-to-date, the strategy has returned +8.12%. Read more here.
SeekingAlpha
ClearBridge Global Value Improvers Strategy Q2 2025 Commentary
SeekingAlpha
ClearBridge International Value Strategy outperformed its benchmark in Q2, boosted by strong stock selection within the industrials and financial sectors.
Yahoo
The nature of investing is that you win some, and you lose some. Unfortunately, shareholders of ICON Public Limited...
